Dale G Nagle Selected Research

Immunotherapy

1/2022	Polymer chimera of stapled oncolytic peptide coupled with anti-PD-L1 peptide boosts immunotherapy of colorectal cancer.
1/2021	Stapled Wasp Venom-Derived Oncolytic Peptides with Side Chains Induce Rapid Membrane Lysis and Prolonged Immune Responses in Melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dale G Nagle Research Topics

Disease

31	Hypoxia (Hypoxemia) 11/2018 - 05/2004
27	Neoplasms (Cancer) 01/2022 - 05/2004
20	Breast Neoplasms (Breast Cancer) 11/2018 - 12/2004
2	Inflammation (Inflammations) 01/2017 - 06/2006
2	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2006 - 08/2005
2	Mycoses (Diseases, Fungus) 04/2006 - 09/2003
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Triple Negative Breast Neoplasms 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Asthma (Bronchial Asthma) 01/2017
1	Respiratory Hypersensitivity 01/2017
1	Eosinophilia 01/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2014
1	Hypersensitivity (Allergy) 12/2012
1	Prostatic Neoplasms (Prostate Cancer) 03/2008
1	Weight Loss (Weight Reduction) 09/2006
1	Reperfusion Injury 01/2006
1	Stroke (Strokes) 01/2006
1	Ischemia 01/2006
1	Myocardial Infarction 01/2006

Drug/Important Bio-Agent (IBA)

14	Transcription Factors (Transcription Factor)IBA 01/2017 - 05/2004
10	Biological ProductsIBA 09/2021 - 01/2006
8	LipidsIBA 09/2011 - 12/2006
7	IronIBA 09/2012 - 05/2004
7	Chelating AgentsIBA 09/2012 - 05/2004
6	Pharmaceutical PreparationsIBA 01/2021 - 02/2009
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2015 - 12/2004
5	Antineoplastic Agents (Antineoplastics)IBA 09/2012 - 05/2004
5	Proteins (Proteins, Gene)FDA Link 09/2011 - 06/2005
4	Oxygen (Dioxygen)IBA 06/2013 - 12/2004
3	Peptides (Polypeptides)IBA 01/2022 - 01/2021
2	MicroRNAs (MicroRNA)IBA 09/2021 - 01/2020
2	SesterterpenesIBA 08/2013 - 11/2007
2	CoumarinsIBA 02/2011 - 11/2010
2	Terpenes (Terpenoids)IBA 11/2008 - 06/2005
2	laurenditerpenolIBA 12/2007 - 12/2004
2	TeaIBA 09/2006 - 12/2004
2	manassantin BIBA 08/2005 - 05/2004
1	PolymersIBA 01/2022
1	Circular RNAIBA 09/2021
1	Biomarkers (Surrogate Marker)IBA 09/2021
1	AntibodiesIBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	Wasp Venoms (Venom, Wasp)IBA 01/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2018
1	Histone Deacetylase InhibitorsIBA 11/2018
1	STA 9090IBA 01/2018
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2018
1	tanespimycin (17AAG)IBA 01/2018
1	Interleukin-5 (Interleukin 5)IBA 01/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017
1	Peroxidase (Myeloperoxidase)IBA 01/2017
1	Interleukin-13IBA 01/2017
1	sampangineIBA 12/2015
1	Cytostatic AgentsIBA 03/2015
1	kalkitoxinIBA 03/2015
1	4-acetoxythorectidaeolide AIBA 08/2013
1	thorectidaeolide AIBA 08/2013
1	luffariellolideIBA 08/2013
1	PoisonsIBA 04/2013
1	auraptenIBA 04/2013
1	Adenosine Triphosphate (ATP)IBA 12/2012
1	Glucose (Dextrose)FDA LinkGeneric 12/2012
1	RotenoneIBA 12/2012
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2012
1	thyrsiferolIBA 06/2011
1	coumarinIBA 11/2010
1	Mammea E-BB compoundIBA 11/2010
1	mycothiazoleIBA 08/2010
1	annonacinIBA 05/2010
1	Complex MixturesIBA 05/2010
1	AcetogeninsIBA 05/2010
1	caulerpinIBA 12/2009
1	Conditioned Culture MediaIBA 12/2009
1	furospongolideIBA 11/2008
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 11/2008
1	matrigelIBA 03/2008
1	CarbamatesIBA 03/2008
1	latrunculin A (LAT-A)IBA 03/2008
1	naphthaleneIBA 11/2007
1	LuciferasesIBA 09/2007
1	PeroxidesIBA 01/2007
1	TriterpenesIBA 12/2006
1	AntioxidantsIBA 09/2006
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2006
1	Interleukin-15 (Interleukin 15)IBA 06/2006
1	Coal Tar (Estar)IBA 06/2006
1	carbazoleIBA 06/2006
1	psammaplin AIBA 04/2006
1	LigandsIBA 04/2006
1	PPAR gammaIBA 04/2006
1	AzolesIBA 04/2006
1	LignansIBA 08/2005
1	manassantin AIBA 08/2005
1	Messenger RNA (mRNA)IBA 08/2005

Therapy/Procedure

4	Therapeutics 01/2017 - 08/2005
2	Immunotherapy 01/2022 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2021 - 07/2004
2	Chemoprevention 09/2006 - 12/2004
1	Complementary Therapies (Alternative Medicine) 05/2010